menu
    • menu

    Company profile for LineaRx

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LineaRx, an Applied DNA Sciences, Inc. company (NASDAQ: APDN) delivers enzymatically-produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (“PCR”) based manufacturing platform, LinearDNA allows for the rap...
    LineaRx, an Applied DNA Sciences, Inc. company (NASDAQ: APDN) delivers enzymatically-produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (“PCR”) based manufacturing platform, LinearDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences. LinearDNA is relevant to a broad array of advanced therapeutics, including mRNA production, DNA vaccines, cell and gene therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LineaRxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Health Sciences Dr, Stony Brook, New York, 11790
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://linearxdna.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/linearx-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/LineaRxDNA

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BNB Plus Corp. Announces European Patent Grant For Fundamental
    BNB Plus Corp. Announces European Patent Grant For Fundamental

    18 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260318656669/en/BNB-Plus-Corp.-Announces-European-Patent-Grant-for-Fundamental-Technology-Underlying-its-Linea-IVT-Platform

    BUSSINESSWIRE
    18 Mar 2026
    Share Share
    BNB Plus Secures 2 LineaDNA Orders from Genetic Medicine Labs
    BNB Plus Secures 2 LineaDNA Orders from Genetic Medicine Labs

    24 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260224243091/en/BNB-Plus-Corp.-BNBX-Receives-Two-New-Orders-for-LineaDNA-from-Genetic-Medicine-Developers

    BUSINESSWIRE
    24 Feb 2026
    Share Share
    BNB Plus Provides BNB Treasury And Operational Updates
    BNB Plus Provides BNB Treasury And Operational Updates

    09 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-09/bnb-plus-provides-bnb-treasury-and-operational-updates

    PHARMIWEB
    09 Dec 2025
    Share Share
    LineaRx to Participate in Upcoming mRNA Industry Conferences
    LineaRx to Participate in Upcoming mRNA Industry Conferences

    18 Jul 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=768588&lang=en

    ACCESSWIRE
    18 Jul 2023
    Share Share
    Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone
    Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone

    10 Aug 2022

    // PRESS RELEASE

    https://adnas.com/lineardna-lnp-lipid-nanoparticles/

    PRESS RELEASE
    10 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search